IL17A and myeloid sarcoma: MS has long been considered a disease mediated by CD4+ T cells, with Th1/Th17 effector cells (Teff) considered to adopt the most prominent role in the autoimmune insult through the main cytokines they release, i.e.IFN-γ and IL-17, respectively [1].